Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02613949Not ApplicableCompleted

Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 202

Role: lead

NCT01914679Not ApplicableTerminated

A Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - University of Michigan

Role: collaborator

NCT02211508Not ApplicableTerminated

Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301

Role: lead

NCT01958853Not ApplicableCompleted

Prospective Evaluation of Reduced Impedance Noninvasive Cortical Electrostimulation (RINCE) to Reduce Fibromyalgia Effects - Extension Study

Role: lead

NCT01825954Not ApplicableCompleted

Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - St. Joseph Mercy Oakland

Role: lead

All 5 trials loaded